Malik, Fady I.
San Francisco VA Medical Center · Amgen (United States) · Duke University · University of California, San Francisco · Estudios Clínicos Latinoamérica · Cytokinetics (United States) · Duke Clinical Research Institute
4 papers on CoChatORCID 0000-0002-5597-5759
Most cited papers
- Verified
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., et al. (2021) · New England Journal of Medicine
Heart Failure Treatment and ManagementCardiomyopathy and Myosin Studies
Cited by 656
- Verified
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study
Teerlink, J. R., Clarke, C. P., Saikali, K. G., Lee, J. H., Chen, M. M., Escandon, R. D., Elliott, L., Bee, R., Habibzadeh, M. R., Goldman, J. H., et al. (2011) · The Lancet
Heart Failure Treatment and ManagementCardiomyopathy and Myosin Studies
Cited by 262
- Verified
Tubulin GTP hydrolysis influences the structure, mechanical properties, and kinesin-driven transport of microtubules
Vale, R. D., Coppin, C. M., Malik, F., Kull, F. J., & Milligan, R. A. (1994) · Journal of Biological Chemistry
Microtubule and mitosis dynamicsCellular Mechanics and Interactions
Cited by 111
- Verified
Fast skeletal muscle troponin activator CK-2066260 increases fatigue resistance by reducing the energetic cost of muscle contraction
Cheng, A. J., Hwee, D. T., Kim, L. H., Durham, N., Yang, H. T., Hinken, A. C., Kennedy, A. R., Terjung, R. L., Jasper, J. R., Malik, F. I., et al. (2019) · The Journal of Physiology
Muscle Physiology and DisordersCardiovascular and exercise physiology
Cited by 41
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free